Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Analytical Method Development: SOP for System Performance Qualification of FTIR Spectrophotometer – V 2.0

Posted on By

Analytical Method Development: SOP for System Performance Qualification of FTIR Spectrophotometer – V 2.0

Standard Operating Procedure for Performance Qualification of FTIR Spectrophotometer in Analytical Method Development


Department Analytical Method Development
SOP No. SOP/AMD/338/2025
Supersedes SOP/AMD/338/2022
Page No. Page 1 of 12
Issue Date 01/06/2025
Effective Date 03/06/2025
Review Date 01/06/2026

1. Purpose

This SOP describes the process for executing system performance qualification (PQ) of Fourier Transform Infrared (FTIR) Spectrophotometers used in Analytical Method Development (AMD) laboratories. It ensures the instrument

complies with regulatory standards for spectral accuracy, reproducibility, and baseline performance before it is used for sample analysis.

2. Scope

This procedure is applicable to all FTIR spectrophotometers used within the AMD department, including those designated for routine sample analysis, method validation, and raw material identification.

3. Responsibilities

  • Analytical Scientist: Conducts PQ checks and records results in prescribed templates.
  • QA Executive: Reviews PQ data for compliance and authorizes release of instrument for analytical use.
  • Instrument Coordinator: Maintains PQ schedule and calibration history.
See also  Analytical Method Development: SOP for Handling and Verification of Blank and Placebo Interference - V 2.0

4. Accountability

The Head of Analytical Method Development is responsible for ensuring that all FTIR instruments are qualified prior to usage and that documented evidence supports their performance reliability.

5. Procedure

5.1 Pre-Qualification Requirements

  1. Ensure the FTIR instrument is installed and calibrated.
  2. Use certified polystyrene film (e.g., 0.05 mm thickness) for performance checks.
  3. Ensure the instrument’s environment is clean, with minimal vibration and temperature control between 20–25°C.

5.2 Wavenumber Accuracy Test

  1. Place certified polystyrene film on the sample compartment.
  2. Scan from 4000 cm-1 to 600 cm-1.
  3. Verify absorption bands at 3060.0 cm-1, 2849.5 cm-1, 1942.9 cm-1, 1601.2 cm-1, 1583.0 cm-1, 1154.5 cm-1, and 1028.3 cm-1.
  4. Ensure band positions are within ±1.0 cm-1 tolerance.

5.3 Resolution Test

  1. Verify resolution at 1154.5 cm-1 and 1028.3 cm-1 peaks.
  2. The minimum height ratio between the valley at ~1089 cm-1 and the 1028 cm-1 peak must be ≥18:1 (as per USP or manufacturer guidelines).
See also  Analytical Method Development: UV Method for API Assay - V 2.0

5.4 Reproducibility and Signal-to-Noise Ratio

  1. Perform 10 scans using background spectrum.
  2. Calculate noise in baseline region (2200–2000 cm-1) and determine the signal-to-noise ratio.
  3. S/N ratio should meet or exceed manufacturer’s specification (typically ≥30000:1).

5.5 Baseline Flatness and Stability

  1. Scan empty sample compartment 10 times over 4000–600 cm-1.
  2. Record baseline stability and flatness; deviation should be ≤0.01 A over the scan range.

5.6 Data Compilation and Review

  1. Record all results in Annexure-1: FTIR PQ Log.
  2. Attach spectral graphs and software reports to the qualification binder.
  3. Submit completed PQ document for QA review and approval.

6. Abbreviations

  • FTIR: Fourier Transform Infrared Spectrophotometer
  • PQ: Performance Qualification
  • S/N: Signal-to-Noise
  • A: Absorbance
  • QA: Quality Assurance

7. Documents

  1. Annexure-1: FTIR PQ Summary Log
  2. Annexure-2: Certified Polystyrene Reference Sheet
  3. Annexure-3: Baseline and S/N Evaluation Graphs
See also  Analytical Method Development: Troubleshooting Methods Developed in AMD - V 2.0

8. References

  • USP <861>: Infrared Spectroscopy
  • ICH Q2(R1): Validation of Analytical Procedures
  • Instrument Manufacturer Manuals

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name Ritika Sharma Amit Joshi Dr. Kavita Arora
Designation Analyst QA Officer Head – AMD
Department Analytical Method Development Quality Assurance Analytical Method Development

11. Annexures

Annexure-1: FTIR PQ Summary Log

Date Test Performed Acceptance Criteria Results Status
01/06/2025 Wavenumber Accuracy ±1.0 cm-1 Pass Pass
01/06/2025 Resolution ≥18:1 peak ratio Pass Pass

Annexure-2: Certified Polystyrene Reference Sheet

Certified data for standard peak positions for comparison and verification during qualification.

Annexure-3: Baseline and S/N Evaluation Graphs

Printouts of scan showing baseline flatness, signal-to-noise calculations, and spectral integrity signatures.

Revision History:

Revision Date Revision No. Details Reason Approved By
01/06/2025 2.0 Updated with additional resolution and reproducibility parameters Annual SOP update Dr. Kavita Arora
15/07/2022 1.0 Initial Issue New SOP Implementation QA Head
Analytical Method Development V 2.0 Tags:Analytical Method Development SOP, SOP for analytical calculations, SOP for analytical documentation, SOP for analytical instrument calibration, SOP for analytical instrument qualification, SOP for analytical method change control, SOP for analytical method deviation handling, SOP for analytical method documentation practices, SOP for analytical method lifecycle management, SOP for analytical method optimization, SOP for analytical method risk assessment, SOP for analytical method training and competency, SOP for analytical method transfer protocol, SOP for analytical method validation, SOP for forced degradation studies, SOP for HPLC method development, SOP for limit of detection (LOD) determination, SOP for limit of quantitation (LOQ) determination, SOP for method accuracy testing, SOP for method linearity assessment, SOP for method precision evaluation, SOP for method reproducibility, SOP for method robustness testing, SOP for method transfer, SOP for method verification, SOP for qualification of working standards, SOP for reference standard handling, SOP for specificity testing in analytical methods, SOP for stability indicating methods, SOP for system suitability testing

Post navigation

Previous Post: Elixir Department: SOP for Stability Indicating Testing – V 2.0
Next Post: Elixir Department: SOP for Verification of Test Results – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version